LR Health & Beauty SE Finalizes 2025 Annual Report, Confirms Preliminary Results, and Advances Strategic Initiatives

LR Health & Beauty SE publishes its final 2025 annual report, confirming sales of EUR 277.1 million and normalized EBITDA of EUR 22.5 million, while investing in a new production line to drive future growth.

LA Metrowire Staff
Business
LR Health & Beauty SE Finalizes 2025 Annual Report, Confirms Preliminary Results, and Advances Strategic Initiatives

LR Health & Beauty SE, a leading European social commerce company specializing in nutritional supplements and beauty products, has released its final annual report for the fiscal year 2025, confirming the preliminary figures announced earlier. The report underscores the company's solid financial position and its commitment to executing strategic initiatives aimed at optimizing production, logistics, and sales operations.

For the full year 2025, the LR Group generated sales (revenue from goods sold) of EUR 277.1 million, compared to EUR 289.2 million in 2024. The reported EBITDA stood at EUR 16.5 million, down from EUR 27.3 million in the previous year, largely due to one-off effects from the reorganization of the financing structure. However, normalized EBITDA, which excludes these exceptional items, amounted to EUR 22.5 million (2024: EUR 32.6 million), reflecting the underlying operational performance.

Jörg Körfer, CEO of LR Health & Beauty SE, commented: "The 2026 financial year is a transitional year for LR, during which we have laid the groundwork – both financially and strategically – for sustainable business growth and performance. The newly established financing structure gives us the momentum we need to continue to consistently pursue the initiatives we have launched in production, logistics and sales in the second half of the year. In this context, we are committed to working closely with our partners and are continuing to expand these relationships internationally."

Expanding in-house production is a key strategic pillar for the company. As part of its strategic measures, LR is investing over EUR 2 million in a new, high-performance production line, which will centralize the manufacture of its 5in1 product category entirely at its site in Ahlen, Germany. This includes established products such as LR 5in1 Beauty Elixir and LR 5in1 Men's Shot. The new facility is designed to have an annual capacity of up to 40 million units and will also pave the way for further product innovations in modern nutritional supplement concepts.

The full 2025 Annual Report is now available on the company's website at https://ir.lrworld.com.

LR Group, headquartered in Ahlen/Westphalia, operates under the motto "More quality for your life" and produces and distributes high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports personal exchange within its community with efficient digital solutions, including the holistic tool "LR neo," which offers international partners all business-relevant key figures and information in one dashboard.

Since 1985, LR has been firmly established as a "people business" focused on personal consultation. In times of changing working environments, the business model appeals to those seeking more flexibility, better work-life balance, and greater financial independence. The company has also been a leader in aloe vera processing for over 20 years, using only the valuable inside of the leaf for its products, and operates one of the most modern aloe vera production facilities in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families worldwide in cooperation with local institutions. Further information on sustainability efforts can be found in the company's Sustainability Report.

Blockchain Registration

QR Code for Blockchain Registration